PerkinElmer to pay $300M for ViaCell acquisition

PerkinElmer said it will acquire ViaCell for $300 million in a deal that would allow it to expand its genetic screening business and its product offerings in the field of neonatal and prenatal health care. The proposed acquisition of ViaCell, developer of ViaCord -- a product that offers parents a chance to preserve their infant's umbilical cord blood for future medical use -- could conclude this year and is subject to shareholder and regulatory approval.

View Full Article in:

Boston Globe (tiered subscription model), The · International Herald Tribune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI